KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Depreciation & Amortization (CF): 2009-2024

Historic Depreciation & Amortization (CF) for Arbutus Biopharma (ABUS) over the last 16 years, with Dec 2024 value amounting to $1.4 million.

  • Arbutus Biopharma's Depreciation & Amortization (CF) fell 96.73% to $11,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $688,000, marking a year-over-year decrease of 51.41%. This contributed to the annual value of $1.4 million for FY2024, which is 0.28% down from last year.
  • Latest data reveals that Arbutus Biopharma reported Depreciation & Amortization (CF) of $1.4 million as of FY2024, which was down 0.28% from $1.4 million recorded in FY2023.
  • Arbutus Biopharma's Depreciation & Amortization (CF)'s 5-year high stood at $2.0 million during FY2020, with a 5-year trough of $1.4 million in FY2024.
  • In the last 3 years, Arbutus Biopharma's Depreciation & Amortization (CF) had a median value of $1.4 million in 2023 and averaged $1.4 million.
  • Data for Arbutus Biopharma's Depreciation & Amortization (CF) shows a maximum YoY fell of 20.72% (in 2022) over the last 5 years.
  • Arbutus Biopharma's Depreciation & Amortization (CF) (Yearly) stood at $2.0 million in 2020, then decreased by 10.00% to $1.8 million in 2021, then declined by 20.72% to $1.4 million in 2022, then fell by 1.61% to $1.4 million in 2023, then fell by 0.28% to $1.4 million in 2024.